Outcomes from ultrasound follow-up of small complex adnexal masses in women over 50
- PMID: 25068555
- DOI: 10.1016/j.ajog.2014.07.044
Outcomes from ultrasound follow-up of small complex adnexal masses in women over 50
Abstract
Objective: The discovery of a complex adnexal mass in an older woman often raises concern for cancer. We evaluate outcomes for a large population-based cohort of women older than age 50 years with a small complex adnexal mass reported on ultrasound, without elevated CA125 or other evidence of malignancy, including time to detection of malignancy and stage at diagnosis for those initially observed.
Study design: Women older than age 50 years who had an ultrasound during 2007-2011 reporting a complex adnexal mass 1-6 cm in size were identified. Previous or subsequent pelvic ultrasounds were reviewed to determine when the mass was first identified and whether there was change over time. Women with concurrent elevated CA125, evidence of metastatic disease, or less than 24 months of clinical follow-up were excluded. Surgical pathology from removal and diagnoses of ovarian cancer within 24 months of follow-up were identified.
Results: Among 1363 complex masses identified, 18 cancers or borderline tumors (1.3%; 95% confidence interval, 0.8-2.1%) were found. Six cases were diagnosed among 204 women who had immediate surgery after initial ultrasound (15%), and 12 additional cases were found among 994 women with at least 1 repeat ultrasound (73%). Growth was apparent on ultrasound by 7 months for all borderline and epithelial ovarian cancers. Of the 12 cases diagnosed during follow-up, 10 were found to be stage 1 at surgery.
Conclusion: Among isolated adnexal masses reported as complex and 1-6 cm on pelvic ultrasound in women older than 50 years, the overall risk of malignancy is low. All cases of epithelial cancer and borderline tumor demonstrated growth by 7 months of observation.
Keywords: complex adnexal mass; ovarian cancer; ultrasound.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses.Am J Obstet Gynecol. 2020 Jan;222(1):56.e1-56.e17. doi: 10.1016/j.ajog.2019.07.031. Epub 2019 Jul 24. Am J Obstet Gynecol. 2020. PMID: 31351062 Free PMC article.
-
Validation of ADNEX and IOTA two-step strategy and estimation of risk of complications during follow-up of adnexal masses in low-risk population.Ultrasound Obstet Gynecol. 2024 Sep;64(3):395-404. doi: 10.1002/uog.27642. Epub 2024 Aug 16. Ultrasound Obstet Gynecol. 2024. PMID: 38477179
-
The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer.Am J Obstet Gynecol. 2005 Apr;192(4):1214-21; discussion 1221-2. doi: 10.1016/j.ajog.2005.01.041. Am J Obstet Gynecol. 2005. PMID: 15846205
-
Clinical management of incidental findings on pelvic adnexal masses.Rev Assoc Med Bras (1992). 2015 Sep-Oct;61(5):469-73. doi: 10.1590/1806-9282.61.05.469. Rev Assoc Med Bras (1992). 2015. PMID: 26603011 Review.
-
CEA in evaluation of adnexal mass: retrospective cohort analysis and review of the literature.Int J Biol Markers. 2015 Nov 11;30(4):e394-400. doi: 10.5301/jbm.5000158. Int J Biol Markers. 2015. PMID: 26109367 Review.
Cited by
-
Management of the Adnexal Mass: Considerations for the Family Medicine Physician.Front Med (Lausanne). 2022 Jul 5;9:913549. doi: 10.3389/fmed.2022.913549. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35865172 Free PMC article.
-
Detection of early stage ovarian cancer in a large community cohort.Cancer Med. 2019 Nov;8(16):7133-7140. doi: 10.1002/cam4.2522. Epub 2019 Sep 30. Cancer Med. 2019. PMID: 31568690 Free PMC article.
-
Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials.Diagnostics (Basel). 2017 Apr 28;7(2):25. doi: 10.3390/diagnostics7020025. Diagnostics (Basel). 2017. PMID: 28452952 Free PMC article. Review.
-
Comparison of two protocols for the management of asymptomatic postmenopausal women with adnexal tumours - a randomised controlled trial of RMI/RCOG vs Simple Rules.Br J Cancer. 2017 Feb 28;116(5):584-591. doi: 10.1038/bjc.2017.17. Epub 2017 Feb 2. Br J Cancer. 2017. PMID: 28152542 Free PMC article. Clinical Trial.
-
The End of the Hysterectomy Epidemic and Endometrial Cancer Incidence: What Are the Unintended Consequences of Declining Hysterectomy Rates?Front Oncol. 2016 Apr 14;6:89. doi: 10.3389/fonc.2016.00089. eCollection 2016. Front Oncol. 2016. PMID: 27148481 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
